Jerald L. Cohen

Improved left ventricular endocardial border delineation and opacification with OPTISON (FS069), a new echocardiographic contrast agent

Jerald L. Cohen, Jorge Cheirif, Douglas S. Segar et al. · Journal of the American College of Cardiology · 1998 · 296 citations

Medicine, Cardiology, Radiology +13

Dobutamine digital echocardiography for detecting coronary artery disease

Jerald L. Cohen, Trevor Greene, John E. Ottenweller et al. · The American Journal of Cardiology · 1991 · 229 citations

Medicine, Cardiology, Radiology +14

Efficacy and safety of the novel ultrasound contrast agent perflutren (definity) in patients with suboptimal baseline left ventricular echocardiographic images∗∗A list of participating investigators appears in the Appendix.

Dalane W. Kitzman, Martin E. Goldman, Linda D. Gillam et al. · The American Journal of Cardiology · 2000 · 164 citations

Medicine, Cardiology, Internal Medicine +14

Phase III multicenter trial comparing the efficacy of 2% dodecafluoropentane emulsion (EchoGen) and sonicated 5% human albumin (Albunex) as ultrasound contrast agents in patients with suboptimal echocardiograms

Paul Grayburn, James L. Weiss, Terrence C. Hack et al. · Journal of the American College of Cardiology · 1998 · 105 citations

Medicine, Cardiology, Pharmacology +16

Comparison of dobutamine and exercise echocardiography for detecting coronary artery disease

Jerald L. Cohen, John E. Ottenweller, Achenkunju K. George et al. · The American Journal of Cardiology · 1993 · 102 citations

Medicine, Cardiology, Clinical Cardiology +13